AbbVie Inc. reports $15 billion revenue for quarter ended March 31, 2026, up 12.4%

ยท ABBV

AbbVie Inc. reported revenue of $15 billion for the quarter ended March 31, 2026, an increase of 12.4% from the same quarter a year earlier ($13.34 billion).

For the same period it posted net income of $695 million, down 46%, or $0.39 per diluted share (0.72 a year earlier).

That is a net margin of 4.6%.

On Sanad's AAOIFI Standard 21 screen, AbbVie Inc. is currently compliant: interest-bearing debt is 15.6% of market capitalisation (limit 30%), and impure income is 0.4% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on May 8, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More AbbVie Inc. news